Why is "Pertussis vaccine" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-07-02 15:34:30
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Pertussis_vaccine entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-07-02 and was most recently seen on 2026-07-02.
Wikipedia Overview
Pertussis vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective. The effectiveness of the vaccines appears to decrease by between 2 and 10% per year after vaccination, with a more rapid decrease with the acellular vaccines. The vaccine is only available in combination with tetanus and diphtheria vaccines. Pertussis vaccine is estimated to have saved over 500,000 lives in 2002.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
What Is the Tdap Vaccine? - Cleveland Clinic
-
ILiAD bags $115m for pertussis vaccine, and other financings - pharmaphorum
-
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda - The Lancet
-
ILiAD secures $115M to push intranasal pertussis vaccine to Phase III - FirstWord Pharma
-
European Regulator Greenlights New Pertussis Vaccine - Medscape
-
Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children - Nature
-
What to Know About Pertussis (Whooping Cough) - Johns Hopkins Bloomberg School of Public Health
-
ILiAD Biotechnologies Announces $115M Oversubscribed Series B Financing to Advance BPZE1 Pertussis Vaccine - Business Wire
-
Protecting Your Infant from Whooping Cough - American Lung Association
-
Despite high whooping cough activity, Americans unsure about vaccine recommendations - CIDRAP
-
BioNet receives positive EMA opinion on new pertussis vaccine - Pharmafile
-
ILiAD Biotechnologies: $115 Million Series B Closed To Advance Intranasal Pertussis Vaccine - Pulse 2.0
-
The 1970s whooping cough vaccine scare - Gavi, the Vaccine Alliance
-
Whooping cough cases soar as vaccine rates drop among kids - NBC News
-
Everything You Need to Know About the Tdap Vaccine - Verywell Health
-
DPHSS to host 2 pertussis vaccine clinics - The Guam Daily Post
-
Pertussis Surveillance and Trends | Whooping Cough - Centers for Disease Control and Prevention | CDC (.gov)
-
Novel Intranasal Vaccine Shows Promise Against Whooping Cough - EMJ
-
Th1 polarization in Bordetella pertussis vaccine responses is maintained through a positive feedback loop - Nature
-
Recombinant pertussis vaccine may protect teens for at least 5 years - CIDRAP
-
Immune response to pertussis vaccine in COPD patients - Scientific Reports - Nature
-
New children’s pertussis vaccine to appear in Russia in 2026 - Новости GxP
-
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial - The Lancet
-
Thai Doctors Pioneer Next-Gen Pertussis (Whooping Cough) Vaccine: Fewer Doses, Full Protection for Vulnerable Patients” - จุฬาลงกรณ์มหาวิทยาลัย
-
Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model - PNAS
-
Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses | Scientific Reports - Nature
-
Waning potency of pertussis vaccine a significant contributor to recent whooping cough outbreaks - Kaiser Permanente Division of Research
-
newsGP - ATAGI warns of pertussis risk for older adults - Royal Australian College of General Practitioners (RACGP)
-
Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children - The New England Journal of Medicine
-
How immunology can help reverse the pertussis vaccine failure - Nature
-
Survey: Doctors rank pertussis vaccine less important than those for other respiratory diseases - CIDRAP
-
Vaccinating Pregnant Patients - Centers for Disease Control and Prevention | CDC (.gov)
-
Standard Pertussis Vaccine Effective, but Short-lived - respiratory-therapy.com
-
Live attenuated pertussis vaccine for prevention and treatment of allergic airway inflammation in mice - Nature
-
Scientists compete to make best predictions about pertussis vaccine - Medical Xpress
-
Pertussis: a tale of two vaccines - Nature
-
What We’re Reading: Adderall Shortage Continues; Pertussis Vaccine Expanded for Infants; Breast Cancer Death Disparities - The American Journal of Managed Care
-
Your Child's Vaccines: Diphtheria, Tetanus & Pertussis Vaccine (DTaP, Tdap) (for Parents) - Humana - Ohio - KidsHealth
-
Evaluating Efficacy of Pertussis Vaccines in Children - ASM.org
-
About Young Children with a Contraindication to Pertussis-Containing Vaccines - Centers for Disease Control and Prevention | CDC (.gov)
-
Immunologic profiling of the infant immune response to whole-cell and acellular pertussis vaccines | npj Vaccines - Nature
-
Whooping Cough (Pertussis) - National Foundation for Infectious Diseases
-
A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial - The Lancet
-
Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults - The New England Journal of Medicine
-
Whooping cough vaccine for grandparents and others about to meet a newborn - Norton Healthcare
-
FDA Grants Fast Track Status to Intranasal Pertussis Vaccine - Medical Professionals Reference
-
BioNet’s Recombinant Pertussis Vaccine Submitted to European Medicines Agency (EMA) - Business Wire
-
A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection againstBordetella pertussis | Infection and Immunity - ASM Journals
-
Acellular Pertussis vaccine less effective than whole-cell vaccine - 2 Minute Medicine
-
Study Shows Whole-Cell Vaccine Was More Effective Than Acellular Vaccine During California Pertussis Outbreak - Kaiser Permanente Division of Research
-
Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis - Nature
-
Diffuse Vasculitis and Death after Hyperimmunization with Pertussis Vaccine | NEJM - The New England Journal of Medicine
-
Whooping cough cases climb in NH amid growing vaccine hesitancy - Seacoastonline.com
-
Whooping Cough: Tulane Awarded $8.5M to Develop Next-Generation Pertussis Vaccine - Global Biodefense
-
Resurgence of Whooping Cough May Owe to Vaccine’s Inability to Prevent Infections - Boston University
-
The quest for a longer-lasting whooping cough vaccine - BBC
-
Transcriptome signature for dampened Th2 dominance in acellular pertussis vaccine-induced CD4 - Nature
-
Acta Paediatrica | Paediatrics Journal - Wiley Online Library
-
Study suggests birth dose of pertussis vaccine could be safe, effective - Contemporary Pediatrics
-
Improving Immunity with a Next-Generation Whooping Cough Vaccine - the-scientist.com
-
7th Graders Need Pertussis Vaccine to Return to School - San Diego County News Center
-
Pertussis Vaccine Effectiveness - National Vaccine Information Center (NVIC)
-
Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study - Nature
-
Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults - The New England Journal of Medicine
-
ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting - Business Wire
-
Pertussis vaccination responses in COPD patients - News-Medical
-
Five Things to Know About Whooping Cough - American Lung Association
-
Tetanus Vaccine Recommendations - Centers for Disease Control and Prevention | CDC (.gov)
-
Sweden reports increase in whooping cough - Outbreak News Today
-
Protection from the TdaP vaccine doesn't last very long - Harvard Health
-
Priming with Whole-Cell versus Acellular Pertussis Vaccine - The New England Journal of Medicine
-
Whooping Cough Killed 6,000 Kids a Year Before These Ex-Teachers Created a Vaccine - History.com
-
COVID, RSV, flu and whooping cough vaccines available now - Sanford Health News
-
Pertussis vaccine – pregnant women are the target group in the childhood vaccination programme - Tidsskrift for Den norske legeforening
-
Diptheria-tetanus-pertussis vaccine: an interview with Dr. Rudi Eggers, World Health Organisation - News-Medical
-
Whooping cough vaccine encouraged as cases rise - BBC
-
Waning Tdap vaccine effectiveness among adolescents - 2 Minute Medicine
-
Rostec has Developed Russia’s First Diphtheria, Tetanus and Pertussis Vaccine for Adults - Ростех
-
Physicians for Informed Consent Releases New Documents on Risks of Whooping Cough and the Pertussis Vaccine (DTaP and Tdap) - Newswire.com
-
Mayo Clinic Q and A: Vaccine against pertussis effective, but immunity can weaken - Mayo Clinic News Network
-
Unraveling the challenges of pertussis - PNAS
-
Clarifying pertussis in Denmark - The Lancet
-
NIAID Sponsors ILiAD Biotechnologies BPZE1 Pertussis Vaccine Phase 2a Clinical Study at Vanderbilt University - GlobeNewswire
-
ILiAD's pertussis shot successfully joins Trojan horse of childhood vaccines in phase 2 - Fierce Biotech
-
UK to switch to non-polio containing pertussis vaccine for pregnant women - Pulse Today
-
Whooping cough is making a comeback, but the vaccine provides powerful protection - The Conversation
-
Protecting newborns from whooping cough - National Poll on Children's Health
-
Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016–2021 - Wiley Online Library
-
Whooping cough vaccine: The power of first impressions - Medical Xpress
-
Chemical Synthesis and Immunological Evaluation of a Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti-pertussis Vaccine - Wiley Online Library
-
A Placebo-Controlled Trial of a Pertussis-Toxoid Vaccine - The New England Journal of Medicine
-
Pregnant women urged to have pertussis vaccine as cases continue to rise - GPonline
-
Emmes Group to conduct Phase III studies of ILiAD Biotechnologies pertussis vaccine candidate, BPZE1 - ET HealthWorld
-
A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine - The New England Journal of Medicine
-
State Map Shows Rising Whooping Cough Cases as CDC Issues Vaccine Reminder - Newsweek
-
RFK Junior is stoking fears about vaccine safety. Here’s why he’s wrong – and the impact it could have - The Conversation
-
Which pertussis vaccine should you use - GOV.UK
-
Why Is Whooping Cough on the Rise? - Boston University
-
Old pertussis vaccine could help combat food allergy - Royal Australian College of General Practitioners (RACGP)
-
Delaware County school district reports whooping cough cases - Inquirer.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.